Position Paper Jul 11, 2026 · 09:00 7 min read By Daniel Herrmann

How to Select CSV Consulting Services: A Buyer’s Guide

Select CSV consulting services by assessing delivery scope, seniority, governance, quality gates and knowledge transfer for life sciences.

The right CSV consulting service delivers more than documents or additional capacity. It owns a defined outcome, connects the business process, IT and Quality, and leaves your team able to maintain the validated state. Assess explicit deliverables, seniority in execution, transparent decision rights, an independent quality gate and planned knowledge transfer.

Why CVs alone do not support a reliable buying decision

Go-live is approaching. Internal experts are committed elsewhere. Several providers offer GAMP 5 experience, flexible capacity and inspection-ready documentation. Their proposals look similar.

The differences emerge later. Who decides validation scope? Who resolves conflict between the project plan and Quality requirements? Who reviews evidence? Who is accountable when a workstream does not deliver?

Selection should therefore go beyond day rates, available headcount and document lists. It needs an operating model that can be tested before contract award.

The commercial overview of CSV consulting for Pharma and Biotech describes DHC’s scope. This buyer’s guide provides criteria for comparing providers.

Distinguish four engagement models

Model	Suitable when	Main risk
Individual CSV specialist	One defined gap or specialist topic needs support	Dependency on one person and limited steering capacity
Work package	Scope, deliverables and interfaces are stable	Gaps between the package and the overall programme
Managed validation services	Multiple systems or a long-term portfolio require governance	Unclear decision rights and distance from the business process
End-to-end project support	Validation, programme management and execution must be connected	Overlapping responsibilities without explicit decision rights

“Validation as a Service” is not a uniform service standard. It may describe documentation, portfolio governance, tool operation or full project accountability. The contract therefore needs explicit outcomes and boundaries.

Eight criteria for selecting CSV consulting services

1. Outcome scope instead of an activity list

“Support with URS, testing and reporting” describes work but not an outcome. A stronger scope defines approved deliverables, acceptance criteria, Quality gates and exclusions.

2. Seniority in actual delivery

Assess more than the people in the pitch. Ask who will lead workshops, assess risk, review test evidence and report to the steering group. Senior expertise must be present in day-to-day execution.

3. Connection across business, IT and Quality

CSV is not produced in an isolated documentation team. The partner should connect intended use, system architecture, data flows and quality decisions.

4. Risk-based delivery with a correct regulatory boundary

A strong provider does not reduce documentation or testing indiscriminately. It justifies effort using risk, intended use and available evidence.

FDA’s February 2026 CSA guidance supports risk-based assurance for production and QMS software in the medical-device sector. Its scope should not be transferred without qualification to pharmaceutical CGMP systems. The comparison of CSV and Computer Software Assurance explains that boundary.

The second edition of ISPE GAMP 5 provides a risk-based industry framework for GxP computerised systems. It does not replace applicable regulatory requirements; a provider should show how the framework is translated into your intended use and quality system.

5. A defined quality gate

The person who creates evidence should not be the only person approving it. The engagement needs review logic for content, traceability, objective evidence, deviations and the summary report.

6. Integrated programme control

Validation risk affects cutover, migration, training, configuration and supplier planning. The partner should make dependencies visible in the integrated plan, not only manage its own task list.

7. Planned knowledge transfer

The engagement is not sustainable if every later change requires new external support. Procedures, templates, risk logic and open items should be transferred to internal owners in a controlled way.

8. Decision-ready reporting

Status reporting should enable decisions. Useful measures may include approved deliverables, open critical risks, test progress, deviation age, traceability gaps and readiness by gate.

Twelve questions for provider interviews

Which outcome do you own through which gate?
What is explicitly outside scope?
Who will work in the project and at what seniority?
Who owns scope, risk and approval decisions?
How do you connect validation with the programme plan and cutover?
How do you determine testing and documentation depth?
How do you use and assess supplier evidence?
How do you review traceability and objective evidence?
How are deviations and late inputs managed?
Which information reaches the steering group?
How is ownership transferred to the internal team?
Which assumptions can change cost or schedule?

The answers should appear in the scope, governance and project plan. A strong interview without contractual translation does not protect go-live.

Compare proposals with a defensible scorecard

A simple weighting prevents the lowest day rate from winning automatically:

Criterion	Example weighting
Outcome scope and acceptance criteria	20%
Delivery seniority and availability	20%
Method and regulatory scope	15%
Programme integration and governance	15%
Quality gate and evidence review	15%
Handover and team capability	10%
Commercial model	5%

Adjust the weighting to your situation. In a go-live recovery, steering capability may carry more weight. Portfolio models place greater emphasis on governance, scalability and knowledge transfer.

Red flags in a proposal

Only document volumes are sold. The number and names of documents say little about quality and intended use.

The senior team disappears after the pitch. Execution is delegated without transparent handover to changing resources.

Quality becomes an end-stage recipient. Requirements and review criteria are not integrated early.

The customer remains permanently dependent. Templates and decisions cannot be transferred or understood without the provider.

Scope assumptions remain implicit. Migration, interfaces, supplier evidence or deviation management emerge later as change requests.

Evidence from the first 30 days

A new partner should create decision value early. After 30 days, scope, governance, risk, the deliverable plan, Quality gates and the critical path should be clear.

Depending on project maturity, early approved requirements, risk decisions or test packages may also be available. The guide to structuring a CSV project in eight weeks shows one possible cadence.

Frequently asked questions

When are managed validation services appropriate?

When multiple systems, releases or sites need governance through one operating model. Clear portfolio priorities, service levels and internal process and Quality owners are prerequisites.

Is fixed price better than time and materials?

Fixed price works with stable scope and clear acceptance criteria. A phased model may be more honest under high uncertainty. What matters is who assesses scope change and which assumptions underpin the price.

How can you tell whether a CSV proposal is fairly priced?

Do not compare day rates alone. A defensible proposal names deliverables and acceptance criteria, makes assumptions and exclusions visible, and defines how scope changes will be decided. Without this outcome scope, even a low day rate cannot be assessed reliably against budget and go-live risk.

Regulatory and industry sources

Author

Daniel Herrmann Consulting — boutique consultancy for GxP compliance and Computer System Validation in pharma, biotech and MedTech. 15+ years of hands-on expertise. 60+ validated systems. 100 % audit pass rate. 0 critical findings.